By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TG Therapeutics, Inc. 

787 Seventh Avenue
48th Floor
New York  New York  10019  U.S.A.
Phone: 212-554-4484 Fax: 212-554-4531


SEARCH JOBS


Industry
Pharmaceutical






Company News
TG Therapeutics, Inc. (MHA) Announces Novel "Chemo-Free" Triple Therapy Combination Clinical Study For Patients With Chronic Lymphocytic Leukemia And Other B-Cell Malignancies 8/15/2014 7:53:00 AM
TG Therapeutics, Inc. (MHA) Announces Second Quarter 2014 Financial Results And Business Update 7/22/2014 2:41:50 PM
TG Therapeutics, Inc. (MHA) Completes Global Licensing Agreement With Ligand Pharmaceuticals Inc. (LGND) For The Development Of Inhibitors Of IRAK4 6/24/2014 8:58:40 AM
TG Therapeutics, Inc. (MHA) To Present At The 2014 JMP Securities Healthcare Conference 6/23/2014 7:32:49 AM
TG Therapeutics, Inc. (MHA) To Present At The 2014 Wells Fargo Healthcare Conference 6/17/2014 9:17:35 AM
TG Therapeutics, Inc. (MHA)' TG-1101 (Ublituximab) In Combination With Ibrutinib Demonstrates Compelling Clinical Activity And Safety Profile In Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) And Mantle Cell Lymphoma (MCL) 6/13/2014 8:32:12 AM
TG Therapeutics, Inc. (MHA) Announces Clinical Data Presentations For TG-1101 And TGR-1202 At The European Hematology Association Meeting In Milan, Italy 5/23/2014 10:14:13 AM
TG Therapeutics, Inc. (MHA) To Host Conference Call On First Quarter 2014 Financial Results And Business Update 5/9/2014 9:10:08 AM
TG Therapeutics, Inc. (MHA) Provides Update On A Modified TGR-1202 Formulation And Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure 5/8/2014 10:13:20 AM
TG Therapeutics, Inc. (MHA) Announces Clinical Data Presentations At Upcoming Conferences 5/6/2014 9:43:53 AM
12345678910...
//-->